secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001493152-23-045193
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics announces 1-for-8 reverse stock split effective December 20
--------------------------------------------------------------------------

- Reverse stock split at 1-for-8 ratio effective 12:01 a.m. ET on December 20, 2023.
- Common stock trades post-split under symbol BBLG; warrants under BBLGW.
- New CUSIP for common stock is 098070501; par value remains $0.001.
- Authorized shares unchanged; fractional shares rounded up to nearest whole.
- Proportionate adjustments to exercise prices and shares issuable under warrants and equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223045193/0001493152-23-045193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223045193/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer